2021-01-06,Fulcrum Therapeutics to Participate in the H.C. Wainwright BioConnect 2021 Conference
2020-12-09,Is FULC A Good Stock To Buy Now?
2020-12-09,Fulcrum Therapeutics to Host Virtual Key Opinion Leader Event Featuring FTX-6058 for Sickle Cell Disease
2020-12-05,Fulcrum Therapeutics Presents Updated Data on Sickle Cell Disease Program at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
2020-12-03,Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
2020-11-16,Here's Why We're Not Too Worried About Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation
2020-11-13,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
2020-11-10,"Novavax (NVAX) Loss Widens in Q3, Revenues Lag Estimates"
2020-11-10,"Fulcrum Therapeutics' (FULC) Shares March Higher, Can It Continue?"
2020-11-10,Fulcrum Therapeutics Reports Recent Business Highlights andÂ Third Quarter 2020 Financial Results
2020-11-09,Why Fulcrum Therapeutics (FULC) Might Surprise This Earnings Season
2020-11-04,Fulcrum Therapeutics Announces Multiple Presentations During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
2020-11-03,"Fulcrum Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, November 10, 2020 at 8:00 a.m. ET"
2020-10-31,"Kaskela Law LLC Announces Stockholder Investigation of Fulcrum Therapeutics, Inc. - FULC"
2020-10-05,Fulcrum Therapeutics to Initiate Phase 1 Trial with FTX-6058 for Sickle Cell Disease
2020-10-01,Fulcrum Therapeutics Announces Multiple Presentations During the Virtual 25th International Congress  of the World Muscle Society
2020-09-25,Fulcrum Therapeutics Announces Preclinical Proof-of-Concept Data for FTX-6058 at the Virtual 14th Annual Sickle Cell Disease Research & Educational Symposium and  43rd National Sickle Cell Disease Scientific Meeting
2020-09-08,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
2020-08-18,Fulcrum Therapeutics'(NASDAQ:FULC) Share Price Is Down 33% Over The Past Year.
2020-08-11,Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
2020-08-11,Fulcrum Therapeutics Announces Interim Analysis Data from its ReDUX4 Trial in Facioscapulohumeral Muscular Dystrophy (FSHD)
2020-08-10,Why Earnings Season Could Be Great for Fulcrum Therapeutics (FULC)
2020-08-06,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
2020-08-05,"Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 11, 2020 at 8:00 a.m. ET"
2020-07-28,Fulcrum Therapeutics Sees Hammer Chart Pattern: Time to Buy?
2020-07-21,MyoKardia and Fulcrum Therapeutics Announce Multi-Target Collaboration to Discover Novel Targeted Therapies for Genetic Cardiomyopathies
2020-06-24,Is Fulcrum Therapeutics (FULC) Stock a Solid Choice Right Now?
2020-06-24,Fulcrum Therapeutics begins trial of muscle disorder drug for COVID-19 patients
2020-06-24,Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients
2020-06-12,"Do Hedge Funds Love Fulcrum Therapeutics, Inc. (FULC)?"
2020-06-10,Fulcrum Therapeutics Completes $68.5 Million Private Placement
2020-06-10,Fulcrum Therapeutics to Evaluate Losmapimod as Potential Treatment for COVID-19
2020-05-21,Fulcrum Therapeutics Announces Multiple Presentations at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform
2020-05-14,"Fulcrum Therapeutics, Inc. (FULC) Shares March Higher, Can It Continue?"
2020-05-13,"Fulcrum Therapeutics, Inc. (FULC) Q1 2020 Earnings Call Transcript"
2020-05-13,Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results
2020-05-11,Fulcrum Therapeutics to Present at the BofA Securities 2020 Health Care Conference
2020-05-07,"Fulcrum Therapeutics to Host First Quarter 2020 Financial Results Conference Call and Webcast on Wednesday, May 13, 2020 at 8:00 a.m. ET"
2020-04-13,Fulcrum Therapeutics Announces Completion of IND-enabling Safety Studies for FTX-6058 in Sickle Cell Disease
2020-04-02,Fulcrum Therapeutics Provides Business Update on Impact of COVID-19
2020-03-24,Fulcrum Therapeutics Announces Complete Data from Phase 1 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
2020-03-05,Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results
2020-02-28,Fulcrum Therapeutics Joins in Effort to Reframe Rare to Commemorate Rare Disease Day 2020
2020-02-26,Fulcrum Therapeutics Announces Completion of Enrollment in Phase 2b Trial of Losmapimod for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
2020-02-25,"Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Thursday, March 5, 2020 at 8:00 a.m. ET"
2020-02-20,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
2020-01-29,Fulcrum Therapeutics Receives Orphan Drug Designation for Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) and Announces Expanded Patent Portfolio
2020-01-06,Fulcrum Therapeutics Appoints Katina Dorton to its Board of Directors
2019-12-30,Acceleron and Fulcrum Therapeutics Announce Pulmonary Research and Discovery Collaboration Agreement
2019-12-16,"Hedge Funds Have Never Been This Bullish On Fulcrum Therapeutics, Inc. (FULC)"
2019-12-02,Fulcrum Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-14,Fulcrum Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
2019-11-13,Fulcrum Therapeutics to Present at the Stifel 2019 Healthcare Conference
2019-11-06,"Fulcrum Therapeutics to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019"
2019-10-31,"Fulcrum Therapeutics to Host Key Opinion Leader Breakfast Symposium on Facioscapulohumeral Dystrophy (FSHD), on November 7, 2019"
2019-10-04,Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
2019-10-04,Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
2019-10-01,Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting
2019-09-04,"Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs Team"
2019-09-03,Fulcrum Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
2019-08-26,Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
2019-08-20,"Company News For Aug 20, 2019"
2019-08-19,"Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD"
2019-08-01,Fulcrum Therapeutics to Present at the SVB Leerink Spotlight Series: Rare & Genetic Diseases Conference
2019-07-17,Fulcrum Therapeutics Announces Pricing of Initial Public Offering
2019-07-15,"IPO Outlook For The Week: Biotechs, Financial Advisers, Medical Services And The Twitch Of China"
2019-07-14,Fulcrum Therapeutics IPO: What You Need To Know
